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ABSTRACT

E2F Transcription Factor 1 (E2F1)
E2F1 is a transcription factor, in which its expression is increased in
human cancers. “Transcription factor E2F1 binds to and activates
transcription,” in return leading to increased transcription at the G1 and
S phase of the cell cycle (Slansky). The E2F transcription factor family
“plays a crucial role in the control of cell cycle and action of tumor
suppressor proteins and is also a target of the transforming proteins of
small DNA tumor viruses” (NCBI).

METHODS

BACKGROUND

Eukaryotes, such as humans and animals, are made up of their own set
of unique and distinguishable chromosomes. Chromosomes are made
up of chromatins, which consists of proteins, RNA and DNA. Strands of
DNA (deoxyribonucleic acid) are surrounded by histones, which are
categorized as proteins that are essentially found in the nucleus of
eukaryotic cells. Histones are subject to modifications, such as
methylation, which will directly affect the gene expression in DNA.
What is lysine methylation?
Histone modification, such as lysine methylation, occurs on histones H3
and H4. Methylation occurring in lysine residues are catalyzed by
enzymes. “Each of these lysine side chains can be mono-, di- or
trimethylated” (Martin). What is unique in lysine methylation is that it is
able to signal either an activation or repression depending on the site in
return, turning certain genes on or off in a gene expression.
“Methylation on the same site can lead to different outcomes
depending on the number of methyl groups added” (Martin).
What is the role of lysine methylation in E2F1-induced apoptosis?
Lysine methylation of histones plays an essential role in the complex
transitions of chromatin structure, “which regulate[s] the accessibility of
transcription factors to nucleosomal DNA” (Kontaki). Histone lysinemethyltransferases regulates specific gene expressions through the
methylation of transcription factors, such as E2F1. Methylation at lysineK185 stimulates degradation of the protein, and can have opposing
biological outcomes.

PURPOSE OF STUDY

Histone lysine methylation serves an array of important functions. In the
past few years, studies on different organisms have resulted in the
identification of several enzymes that catalyze site-specific histone lysine
methylation. The characterization of these enzymes has revealed
important functions of histone methylation in many different biological
processes that range from heterochromatin formation to transcription
regulation.

METHODS

Figure 2: Western Blotting detects proteins that have been separated by
electrophoresis gel.
Figure 1: Specimen of a small cell lung carcinoma via microscope

Immunoprecipitation
By using the specificity of antibodies, immunoprecipitation (IP) isolates
target proteins, such as antigens, out of sample mixtures (Kaboord). IP
typically tests for protein to protein interactions and is responsible for
the lysis of cells (or lysates).
In a small cell lung carcinoma specimen, a lysis buffer is used to break
down a cell’s wall in order to burst the cell and reveal the proteins that
are inside. In addition, a Tris wash buffer is used to maintain a pH of 7.4.
This keeps the proteins at the right pH, which is relatively neutral and
close to the pH level of blood.
A detergent called sodium dodecyl sulfate (SDS) is added to denature
the lysates. Once all of the proteins are separated in the solution, the
lysates are put in a tube and centrifuged. DNA, RNA, and pieces of the
cell wall are discarded, while the top layer of protein is utilized.
Immediately after denaturation, protease inhibitors are added to stop
protein from degrading since protein degrades quickly, the cells are put
into an ice bath to chill.
Lastly, antibodies derived from rabbit blood are added to the lysates in
order for the antibodies to bind to the protein beads (antigens). These
steps are repeated until the protein of interest is found.
Western Blot
Immunoprecipitation (IP) is used to prep for Western Blotting. Western
Blot uses antibodies to detect proteins that have been separated by
electrophoresis gel. The protein that is retrieved from IP runs through a
gel, which separates the proteins depending on size and shape. The
purpose of Western Blotting is to test for a binding partner. For example,
primary antibodies are able to bind to square proteins that are needed
in the cell cycle. Once an antibody binds to a protein that specific
binding is confirmed.

RESULTS

Lysine methylation alters the amino acid number in a histone. Each
protein has its function, and its function is regulated in many ways.
Through epigenetics, a lung cell is able to turn into a liver cell by
changing the modifier. Transcription factors, such as E2F1, modify and
revolutionize the realm of epigenetics.

CONCLUSIONS

A cancer cell’s metabolic pathway is damaged. In varied cancer stem
cells, proteins that do not typically interact with each other end up
interacting with each other, and that is what starts the proliferation of
tumor masses. Due to the complex and ever-growing nature of cancer
research, further and developing studies will be made in the years to
come. The results will pave the way to many studies regarding cancer
and how to target it at its root.
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